No disclosed relationships extracted for QUCYyet. The EDGAR pass hasn't reached this filing; the graph grows as filings are read.
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
Nothing on the wire mentions QUCY yet. Iris sweeps the public feeds every quarter hour; headlines land here the moment a sweep tags them.
How QUCY has moved on past release days vs its typical ±6.0% day, and how often it closed up. Computed from daily closes — not a forecast.